重大事件
即時報告
8-K
2026-06-11
Tvardi Therapeutics公布股东会投票结果 董事
AI 繁中摘要
Tvardi Therapeutics, Inc.（製藥公司，SIC 2834）於2026年6月11日向SEC提交8-K表格，報告2026年6月9日舉行的股東大會投票結果。本次申報屬於Item 5.07「股東投票事項」，內容涵蓋董事選舉及其他提交表決的提案。文件未列出具體票數或通過與否的細節，投資者須查閱完整申報文件以獲取詳細結果。是次投票反映股東對公司治理及策略方向的表態，可能對未來營運及股價產生影響。📊 建議留意後續季度報告（10-Q）及年報（10-K）的相關更新。
展開英文正文
EDGAR Filing Documents for 0001104659-26-072930 SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001104659-26-072930 Filing Date 2026-06-11 Accepted 2026-06-11 16:05:35 Documents 11 Period of Report 2026-06-09 Items Item 5.07: Submission of Matters to a Vote of Security Holders Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K tm2617528d1_8k.htm iXBRL 8-K 35291 Complete submission text file 0001104659-26-072930.txt 201589 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA tvrd-20260609.xsd EX-101.SCH 3044 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE tvrd-20260609_lab.xml EX-101.LAB 34239 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tvrd-20260609_pre.xml EX-101.PRE 22378 14 EXTRACTED XBRL INSTANCE DOCUMENT tm2617528d1_8k_htm.xml XML 3221 Mailing Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 Business Address 3 SUGAR CREEK CTR. BLVD. STE 525 SUGAR LAND TX 77478 (713) 489-8654 Tvardi Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings) EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36279 | Film No.: 261083042 SIC: 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)